Walden Group Healthcare M&A Blog

  • Walden Group Arranges the sale of Argentum Medical, LLC to Shore Capital Partners

    1/25/2017
    The Walden Group is pleased to announce that it represented Argentum Medical, LLC, an advanced woundcare company, in its sale of equity to Shore Capital Partners. Argentum's core platform technology, Silverlon, is a uniquely designed silver-plated nylon matrix that releases potent silver ions into the wound without staining the skin or increasing...
    Read More
  • EQT (Private Equity) Sells BSN Medical to Svenska Cellulosa Aktiebolaget (SCA)

    12/27/2016
    Sweden's Svenska Cellulosa Aktiebolaget (SCA), $12.3b global hygiene and forest products company, is buying BSN Medical GmbH, a Germany-based manufacturer of woundcare, noninvasive orthopedic  and compression therapy products. The deal weights SCA's business more toward healthcare.  BSN has a major share in several attractive medical product...
    Read More
  • J&J to buy Abbott Medical Optics for $4.3b.

    10/25/2016
    Johnson & Johnson (NYSE: JNJ), a $74.3b manufacturer of pharmaceuticals, medical devices and consumer healthcare products, has agreed to buy Abbott Medical Optics Inc, a global ophthalmic surgical and eye care products company and a unit of Abbott Labs. The deal greatly expands J&J's $7b eye care segment, by adding ophthalmic products...
    Read More
  • Abbott is buying St.Jude Medical Further Consolidating the Medical Device Sector

    05/05/2016
    Abbott Laboratories (NYSE:ABT), a $20.4b maker of diagnostics, medical devices, pharmaceuticals and nutritionals, has agreed to buy St. Jude Medical Inc. (NASDAQ:STJ), a major maker of devices for cardiac rhythm management, cardiovascular, and atrial fibrillation. St. Jude Medical's strong positions in heart failure devices, atrial fibrillation...
    Read More
  • What to Expect for 2016 Healthcare M&A Activity

    01/24/2016
    Recent volatility in worldwide markets, weakness in China, terrorism, softness in Europe and emerging markets, budget issues, and healthcare reform dislocations are among the dynamics that have clouded the 2016 picture for healthcare M&A. Here, we help clarfty things. China China is moving from a manufacturing and investment orientation to a...
    Read More
  • Page 1 of 512345